GenesisCare Adds Five Respected Sub-Specialty Surgeons to Asheville Team to Provide Better Access to Life-Saving Cancer Treatments to Patients

Asheville, NC, April 29, 2021 – GenesisCare—one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom—today announced the addition of five well-respected surgeons to the Asheville team of GenesisCare USA of North Carolina, PA. GenesisCare Surgical Specialists will be working to put into practice more than 20 life-saving surgical procedures providing comprehensive cancer care across medical and radiation oncology. The collection of comprehensive procedures and surgeons allow the facility to offer treatments for breast, colon, pancreatic, thyroid, skin, and other metastatic cancers, which may decrease the number of treatments and severity of side effects for patients.

“Our goal in moving into the U.S. is to elevate the access to life-saving cancer treatments, making it easier for patients everywhere to seek the care they need. This new offering ensures comprehensive treatment in the Asheville and Western North Carolina regions, giving this community increased access to quality care,” said Dan Collins, Founder and CEO, GenesisCare. “This integrated partnership is a testament to our commitment to providing patients access to innovative services with leading experts and state-of-the-art linear accelerators for targeted radiation therapy that will positively impact and change the overall approach to cancer.”

The new surgeons are all board-certified and subspecialty fellowship-trained. Some have worked in the community for more than a decade, and all are focused on using transformational techniques that can help alleviate patients’ apprehensions around surgery. Located at 20 Medical Park Drive in Asheville, the new team includes:

  •  Dr. Paul Ahearne specializes in breast, colon/rectum, gastrointestinal, liver, pancreas, and sarcoma cancer.
  • Dr. Colin Bird specializes in colorectal cancer, anal cancer, Crohn’s/UC, diverticulitis, and anorectal pathology.
  • Dr. Benjamin Deschner specializes in pancreas, breast, colon/rectum, gastrointestinal, adrenal, and skin cancer.
  • Dr. Ioanna Mazotas specializes in adrenal nodules, hyperparathyroidism, hyperthyroidism, thyroid cancer, and thyroid nodules.
  •  Dr. Melissa Zoumberos specializes in colorectal cancer, anal cancer, Crohn’s/UC, diverticulitis, and anorectal pathology.

“Being able to provide a complete approach to diagnosing and treating cancer is crucial to the rate of success. GenesisCare is proud to be able to support cancer patients in the entire region with access to a convenient unified surgical, medical, and radiation oncology team without them having to travel long distances,” said Dr. Quinten Black, GenesisCare Radiation Oncologist. “Our patient-centered outcomes and focused technical support will deliver on the promise of exceptional experience and better outcomes for every patient’s cancer journey in the community.”

The company is investing millions in providing new hope and technology to the region and community; GenesisCare Surgical Specialists key differentiators include:

  • The only two fellowship-trained colorectal surgeons in Western North Carolina
  • The only fellowship-trained endocrine surgeon in all of Western North Carolina
  • One of the only board-certified surgical oncologists in the community

All five sub-specialty surgeons use traditional and cutting-edge techniques, including robotic surgeries. “Working with GenesisCare ensures we’ll be able to continue to provide innovative, life-saving procedures to residents in the community and across the region,” said Dr. Paul Ahearne, GenesisCare Surgical Oncologist. “Our team’s goal is to provide healthcare with dignity and respect for patients that are often dealing with perhaps one of the most trying times of their lives,” continued Dr. Ahearne.

As a leading provider of oncology services globally, GenesisCare strives to ensure its patients’ best possible life outcomes by bridging the gap between integrated cancer care, research and development, and medical technology. With its origins in radiation oncology, GenesisCare has, in recent years, expanded its services to include medical oncology, urology, and a cutting-edge form of nuclear medicine.

For more information on GenesisCare, visit genesiscare.com/us (formerly 21st Century Oncology). To view the complete list of precautions GenesisCare US centers are taking to ensure patient and staff safety, visit https://www.genesiscare.com/us/covid-19/.

Related articles

GenesisCare and PreludeDxTM Form Precision Medicine Global Partnership

GenesisCare Brings Western North Carolina Cancer Patients Elekta Versa HD™ Technology

Lantheus Selects GenesisCare to Administer First Commercial dose of PYLARIFY®, the first and only FDA-Approved PSMA PET Imaging Agent for Men with Prostate Cancer

GenesisCare Brings Western North Carolina Cancer Patients Elekta Versa HD™ Technology